ReviewReviews in endocrine & metabolic disorders2026
Endocrine-disrupting chemicals in cosmetics: mechanistic insights and their impact on human and skin health.
Review in Reviews in endocrine & metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing use of cosmetics and therapeutic products has raised concerns about their effects on skin health and overall well-being. This review focuses on the toxicological impact of cosmetic ingredients, particularly endocrine-disrupting chemicals (EDCs) such as benzophenones, triclosan, phthalates, and parabens. Frequently present in skincare, haircare, and cosmetic products, these compounds have been associated with adverse outcomes, including carcinogenesis, skin disorders, hormonal imbalances, and reproductive health issues. Despite extensive research on parabens, phthalates, triclosan, and benzophenones, significant uncertainties persist, underscoring the need for further investigation to understand previous findings better. To mitigate these risks, the review recommends adopting safer alternatives, increasing consumer awareness, and enforcing stricter regulatory measures. This comprehensive analysis aims to bridge existing knowledge gaps, empower consumers to make informed choices, and advocate for strict safety standards in personal care products to safeguard skin health and support long-term well-being.
Indexed as
Identifiers
41307807What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.